Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | P2RX1 | P51575 | 7/20 | 0.54 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | TMPRSS4 | Q9NRS4 | 4/20 | 0.53 |
| ▸ | P2RX4 | Q99571 | 3/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.49 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19326233 | 0.85 | CDK1 (0.65) | CDK1TDP1MEN1KMT2AP2RX1 | |
| SCHEMBL8980687 | 0.84 | CDK1 (0.82) | CDK1TDP1P2RX1KCNMA1PTGS1 | |
| SCHEMBL1114775 | 0.81 | CDK1 (0.68) | CDK1TDP1MEN1KMT2AP2RX1 | |
| SCHEMBL3506141 | 0.81 | POLB (0.71) | TDP1MAOBCYP1A2TSHRNFKB1 | |
| SCHEMBL17774862 | 0.81 | ALOX5 (0.55) | CDK1TDP1MAOBCYP1A2TSHR | |
| SCHEMBL23675381 | 0.80 | CDK1 (0.76) | CDK1TDP1MEN1KMT2AP2RX1 | |
| SCHEMBL3277584 | 0.80 | ALDH1A1 (0.70) | CDK1TDP1MEN1KMT2AP2RX1 | |
| Hydrochloric Acid SCHEMBL9585953 | 0.79 | POLB (0.69) | TDP1MAOBCYP1A2TSHRNFKB1 | |
| SCHEMBL24454271 | 0.79 | CSNK2A1 (0.51) | CDK1MEN1KMT2AP2RX1TMPRSS4 | |
| SCHEMBL2330956 | 0.79 | CDK1 (0.74) | CDK1TDP1MEN1KMT2AP2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1372615-B1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2013-04-24 | — | — | EP | disclosed |
| EP-2308479-A2 | Compounds and compositions for delivering active agents | Emisphere Technologies, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| US-7700775-B2 | Compounds and compositions for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-20040097500-A1 | Compounds and compositions for delivering active agents | NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097500-A1 | Compounds and compositions for delivering active agents | SERPINB1, ELANE, MMP8 | CDK1 2645/4885TDP1 2710/4885MAOB 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.